Skip to main content
Dexpramipexole is ineffective in two models of ALS related neurodegeneration
Published Web Location
http://europepmc.org/articles/PMC4272269?pdf=renderNo data is associated with this publication.
Abstract
© 2014 Vieira et al.Treatment options for people living with amyotrophic lateral sclerosis (ALS) are limited and ineffective. Recently, dexpramipexole (RPPX) was advanced into human ALS clinical trials. In the current studies, we investigated RPPX in two p
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.